HuidaGene Therapeutics announces that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved its investigational new drug (IND) application for the planned multi-regional, multi-national clinical trial of HG004.
Phio Pharmaceuticals Corp. today announced that in vivo data from a mouse model of colon cancer demonstrates target synergy-enhanced anti-tumor efficacy from a novel dual-targeting mouse PD-1 and CTLA-4 of an INTASYL coformulation.
Coeptis Therapeutics Holdings, Inc. announced it has entered into a binding term sheet with Deverra Therapeutics, Inc. (“Deverra Therapeutics”) pursuant to which it has obtained an exclusive right, until August 31, 2023.
Palatin Technologies, Inc. today announced The International Journal of Molecular Sciences published a manuscript, “Stimulating the Melanocortin System in Uveitis and Diabetes Preserves the Structure and Anti-Inflammatory Activity of the Retina” by Tat Fong Ng and Andrew W. Taylor from Department of Ophthalmology, Boston University Chobanian and Avedisian School of Medicine, in Boston, Massachusetts.
A unanimous FDA committee vote supported the favorable risk-benefit profile of Innoviva’s sulbactam-durlobactam for hospital-acquired A. baumannii infections.
FDA Adcomm Backs Innoviva’s Pneumonia Antibiotic Read More »
Ampio Pharmaceuticals, Inc. released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.
Ampio Pharmaceuticals Issues Letter to Stockholders – April 18, 2023 Read More »
Algunos de los asteroides que Lucy visitará se encuentran aún a más de 530 millones de kilómetros de la nave espacial, lo que supone más del triple de la distancia media entre la Tierra y el Sol. Pero a pesar de la gran distancia y de los tamaños peque&ntild …
La sonda espacial Lucy observa de lejos asteroides que visitará Read More »
El helicóptero robótico Ingenuity de la NASA ha efectuado su vuelo número 50 en Marte. El Ingenuity, que es la primera aeronave en volar en otro mundo, realizó ese vuelo número 50 el 13 de abril, recorriendo más de 322,2 metros en 145,7 segundos. El …
Ondine Biomedical Inc. presented detailed results from its US Phase 2 BENEFIT-aPDT clinical trial to the 33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark.
Ondine Biomedical’s Nasal Photodisinfection Cuts Surgical Site Infections by 66% Read More »
Nordic Nanovector ASA announces that full results from its Phase 2 clinical trials of Betalutin® in resistant/refractory indolent non-Hodgkin’s lymphoma have been published at EudraCT, the European Union Drug Regulating Authorities Clinical Trials Database of the European Union.
